Delivery Order SPE2DB22D1017-SPE2DB25FYSFB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,773.00 to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count) on August 25, 2025, with completion scheduled for August 26, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a $3,029.76 delivery order to AmerisourceBergen Drug Corp for Telmisartan 80 mg tablets (30-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Telmisartan 20 mg tablets (30-count) valued at $11,635.07. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. As a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,942.04 to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under...
- The Defense Logistics Agency awarded a delivery order valued at $1,859.07 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on June 18, 2025, with completion scheduled for June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Telmisartan 20 mg tablets in quantities of 30 units, with a ceiling value of $2,015.02. This contract is a firm fixed-price delivery order with an ultimate completion date of May 13, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Telmisartan 80 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract was executed on August 4, 2025, with a ceiling value of $3,660.86 and an ultimate completion date of August 5, 2025. The contract utilizes firm fixed pricing and represents a delivery order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Telmisartan 80 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,924.44 with a firm fixed price structure and an ultimate completion date of August 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Telmisartan 80 mg tablets (30-count units) under a firm fixed-price contract valued at $4,706.88. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 11, 2025. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract executed...
- The Defense Logistics Agency awarded a delivery order valued at $4,832.84 to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively through an open procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYSFBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Telmisartan 80 mg tablets (30-count units) valued at $1,276.09. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA Troop Support Medical contract represents a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Telmisartan, an antihypertensive medication, exemplifies the company's role in providing essential pharmaceutical products to support Defense Health Agency operations and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/28/25 |